Ana P. Candiota
Bellaterra, CT 08913, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma.
Journal: International journal of molecular sciences
Published: September 13, 2024
Synthesis and Relaxivity study of amino acid-branched radical dendrimers as MRI contrast agents for potential brain tumor imaging.
Journal: Acta biomaterialia
Published: August 12, 2024
Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice.
Journal: International journal of molecular sciences
Published: October 31, 2023
Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks.
Journal: Cancers
Published: June 07, 2023
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
Journal: Nanomaterials (Basel, Switzerland)
Published: April 12, 2023
Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.
Journal: International journal of molecular sciences
Published: December 16, 2022
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Journal: Cancers
Published: August 30, 2022
Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 03, 2022
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives.
Journal: Metabolites
Published: February 07, 2022
Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment.
Journal: Cancers
Published: November 25, 2021
Last Updated: 09/26/2026